HIMSS TV
Emmanuel Bilbault, cofounder and CEO of POSOS, says the company's AI-powered clinical support platform offers alternate drugs to prescribe to avoid interaction risk, rather than simply alert doctors of possible medication errors.
Fay Stevenson, ICT director at Barts Health NHS Trust, shares learnings and best practices from the trust's INFRAM journey, including the need to understand existing technology before deciding how to replace or build onto it.
SPONSORED
Hee-Eun Ahn and Min-Young Song, product leads at South Korea's AIMMED, discuss Somzz, a medical device offering insomnia interventions, and Snuz, a sleep-management app powered by GPT4-o that will be available globally in August 2024.
Kaiser Permanente Georgia is getting more patients booked and into imaging, thanks to new equipment that completes PT scans in half the time. It's also improving patient experiences and reducing duplication, says Heidi Veltman, VP & COO.
Steven Osborne, Medweb's director of federal business, discusses the company's new teledermatology app, which compresses the highest-resolution images a patient's phone can take without compromising data quality for a doctor's review.
Virtual reality is particularly beneficial for teaching social and life skills, says Floreo CEO Vijay Ravindran, who explains and how investment in extended-reality digital therapeutics is evolving.
An online community for atrial fibrillation will connect patients and caretakers with information on the disease and help to increase beneficial partnerships, says Jim Kaveney, founder of Unlimited Heart Health & Wellness.
An AI-enabled system at Lee Health can refer chronic heart failure patients discharged from its hospitals to the RPM programs of Dr. Zsolt Kulcsar, the provider's medical director of virtual health. He explains how it works.
Zubin Khambatta, a healthcare attorney and partner at Holland & Knight, unpacks the rule, which was to go into effect on July 9 but has been challenged by the state of Texas.
Tabia Health's AI-powered complex chronic disease-management platform has nearly doubled treatment-adherence rates, say company cofounders Steve Pickett and Ricardo Clemente.
